Cardiopulmonary bypass leads to a preferential loss of activated platelets: A flow cytometric assay of platelet surface antigens

European Journal of Cardio-thoracic Surgery

Volumn 10, Issue 9, 1996, Pages 768-773

  Wahba, A ^a   Black, G ^a   Koksch, M ^a   Rothe, G ^a   Preuner, J ^a   Schmitz, G ^a   Birnbaum, D E ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cardiopulmonary bypass; Flow cytometry; Glycoproteins; Heparin; Platelet function

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; GLYCOPROTEIN GP 140; HEPARIN; LEUKOCYTE ANTIGEN; LYSOSOMAL PROTEIN GP53; THROMBIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; CARDIOPULMONARY BYPASS; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; THROMBOCYTE ACTIVATION; THROMBOCYTE DISORDER;

ADULT; AGED; ANTICOAGULANTS; ANTIGENS, CD; BLOOD PLATELET DISORDERS; CARDIOPULMONARY BYPASS; FLOW CYTOMETRY; GLYCOPROTEINS; HEPARIN; HUMANS; MIDDLE AGED; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; PROSPECTIVE STUDIES;

EID: 0030347291     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(96)80338-1     Document Type: Article

References (28)

1. Boldt J, Zickmann B, Benson M, Dapper F, Hempelmann G, Schindler E (1993) Does platelet size correlate with function in patients undergoing cardiac surgery? Intensive Care Med 19:44-47
2. Boonstra PW, Van Imhoff GW, Eysman L, Kootstrat GJ, Van der Heide H, Karliczek GF, Wildevuur CRH (1985) Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusions. J Thorac Cardiovasc Surg 89:900-906
3. Colman RW (1990) Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 49:32-34
4. De Haan J, Boonstra PW, Monnink SHJ, Ebels T, Van Oeveren W (1995) Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Ann Thorac Surg 59:901-907
5. Dechavanne M, Ffrench M, Pages J, Ffrench P, Boukerche H, Bryon PA, McGregor JL (1987) Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb/IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation. Thromb Haemost 57:106-109
6. George JN, Nurden AT, Phillips DR (1984) Molecular defects in interactions of platelets with the vessel wall. N Engl J Med 311:1084-1098
7. George JN, Pickett EB, Saucerman S, McEver RP, Kunickl TJ, Kieffer N, Newman PJ (1986) Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observation in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 78:340-348
8. Harker LA, Malpass TW, Branson HE, Hessel II EA, Slichter SJ (1980) Mechanism of abnormal bleeding in patients undergoing cardiopulmonar bypass: acquired transient platelet dysfunction associated with selective α-granule release. Blood 56:824-834
9. Hourani SMO, Hall DA (1994) Receptors for ADP on human blood platelets. Trends Pharmacol Sci 15:103-108
10. Hourdille P, Heilmann I, Combire R, Winkler J, Clementson KJ, Nurden AT (1990) Thrombin induces a rapid redistribution of glycocoprotein Ib-IX complexes within the membrane systems of activated human platelets. Blood 76:1503-1513
11. Huang H, Ding W, Su Z, Zhang W (1993) Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 106:11-18
12. Kestin AS, Shukri CR, Loscalzo J, Ellis PA, MacGregor H, Birjiniuk V, Quimet H, Pasche B, Nelson MJ, Benoit SE, Rodino LJ, Barnard MR, Michelson AD (1993) The platelet function defect of cardiopulmonary bypass. Blood 82:107-117
13. Michelson AD, Barnard R (1987) Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex. Blood 70:1673-1678
14. Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS (1991) Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, ADP or an in vivo wound. Blood 77:770-779
15. Mohr R, Goor DA, Lusky A, Lavee J (1992) Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction. A scanning electron microscopy study. Circulation 86(Suppl II):405-409
16. Nieuwenhuis HK, Van Oosterhout JJG, Rozemuller E, Van Iwaarden F, Sixma JJ (1987) Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 70:838-845
17. Nurden AT, Macchi L, Bihour C, Durrieu C, Besse P, Nurden P (1994) Markers of platelet activation in coronary heart disease patients. Eur J Clin Invest 24 (Suppl I):42-45
18. Ray MJ, Hawson GAT, Just SJE, McLachlan G, O'Brien M (1994) Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 57:981-986
19. Rinder CS, Bohnert J, Rinder HM, Mitchell J, Ault K, Hillman R (1991) Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology 75:388-393
20. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR (1991) Modulation of platelet surface adhesion receptors during cardiopulmonary bypass surgery. Anesthesiology 75:563-570
21. Tabuchi N, De Haan J, Boonstra PW, Gallandat Huet RCG, Van Oeveren W (1994) Aprotinin effect on platelet function and clotting during cardiopulmonary bypass. Eur J Cardiothorac Surg 8:87-90
22. Tamari Y, Aledort L, Puszkin E, Degnon TJ, Wagner N, Kaplitt MJ, Peirce EC (1975) Functional changes in platelets during extracorporeal circulation. Ann Thorac Surg 19:639-647
23. Valeri CR, Khabbaz K, Khuri SF, Marquardt C, Ragno G, Feingold H, Gray AD, Axford T (1992) Effect of skin temperature on platelet function in patients undergoing extracorporeal bypass. J Thorac Cardiovasc Surg 104:108-116
24. Van Oeveren W, Harder MP, Roonzendaal KJ, Eijsman L, Wildevuur CRH (1990) Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 99:788-797
25. Vandenfelde Ch, Fondu P, Dubois-Primo J (1991) Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass. Lancet 337:1157-1158
26. Wenger RK, Lukasiewicz H, Mikuta BS, Niewiarowski S, Edmunds LH (1989) Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 97:235-239
27. Woodman RC, Harker LA (1990) Bleeding complications associated with cardiopulmonary bypass. Blood 76:1680-1697
28. Zilla P, Fasol R, Groscurth P, Klepetko W, Reichenspurner H, Wolner E (1989) Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation. J Thorac Cardiovasc Surg 97:379-388